alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)-beta-D-GlcpNAc

Term ID

CHEBI:42088

Synonyms

6-deoxy-alpha-L-galactopyranosyl-(1->2)-beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-beta-D-glucopyranose
alpha-L-Fuc-(1->2)-beta-D-Gal-(1->4)-beta-D-GlcNAc
alpha-L-fucopyranosyl-(1->2)-beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-beta-D-glucopyranose
alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->4)-N-beta-D-glucosamine
beta-D-glucopyranose, O-6-deoxy-alpha-L-galactopyranosyl-(1->2)-O-beta-D-galactopyranosyl-(1->4)-2-(acetylamino)-2-deoxy-
Fuca1-2Galb1-4GlcNAcb
H type 2
H type II
human blood group H type 2 trisaccharide
O-6-deoxy-alpha-L-galactopyranosyl-(1->2)-O-beta-D-galactopyranosyl-(1->4)-2-(acetylamino)-2-deoxy-beta-D-glucopyranose
WURCS=2.0/3,3,2/[a2122h-1b_1-5_2*NCC/3=O][a2112h-1b_1-5][a1221m-1a_1-5]/1-2-3/a4-b1_b2-c1

Definition

An amino trisaccharide consisting of alpha-L-fucose, beta-D-galactose and N-acetyl-beta-D-glucosamine residues joined by sequential (1->2)- and (1->4)-linkages.

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)-D-GlcpNAc

alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)-D-GlcpNAc Show first 5 Terms
inverse has_functional_parent: alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminide alpha-L-Fucp-(1->2)-beta-D-Galp3Me-(1->4)-beta-D-GlcpNAc

alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminide alpha-L-Fucp-(1->2)-beta-D-Galp3Me-(1->4)-beta-D-GlcpNAc Show first 5 Terms
inverse is_substituent_group_from: alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)-beta-D-GlcpNAc-yl group

alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)-beta-D-GlcpNAc-yl group Show first 5 Terms

Phenotype

Phenotype resulting from alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)-beta-D-GlcpNAc

Phenotype where environments contain alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)-beta-D-GlcpNAc

Phenotype modified by environments containing alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)-beta-D-GlcpNAc

Human Disease Model